User profiles for Athol Wells
Athol U WellsProfessor of Respiratory Medicine, Imperial College, Verified email at rbht.nhs.uk Cited by 98124 |
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
…, DA Lynch, JH Ryu, JJ Swigris, AU Wells… - American journal of …, 2011 - atsjournals.org
This document is an international evidence-based guideline on the diagnosis and management
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …
of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic …
An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …
Background: In 2002 the American Thoracic Society/European Respiratory Society (ATS/ERS)
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …
classification of idiopathic interstitial pneumonias (IIPs) defined seven specific entities, …
Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline
Background: This document provides clinical recommendations for the diagnosis of
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …
idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American …
The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society
…, CM Schaefer-Prokop, N Tomiyama, AU Wells… - Radiology, 2020 - pubs.rsna.org
With more than 900 000 confirmed cases worldwide and nearly 50 000 deaths during the
first 3 months of 2020, the coronavirus disease 2019 (COVID-19) pandemic has emerged as …
first 3 months of 2020, the coronavirus disease 2019 (COVID-19) pandemic has emerged as …
[HTML][HTML] Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the end …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the end …
[HTML][HTML] Nintedanib in progressive fibrosing interstitial lung diseases
Background Preclinical data have suggested that nintedanib, an intracellular inhibitor of
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …
tyrosine kinases, inhibits processes involved in the progression of lung fibrosis. Although the …
An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline
Background: This document updates the American Thoracic Society/European Respiratory
Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on …
Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on …
Acute exacerbations of idiopathic pulmonary fibrosis
The natural history of idiopathic pulmonary fibrosis (IPF) has been characterized as a steady,
predictable decline in lung function over time. Recent evidence suggests that some …
predictable decline in lung function over time. Recent evidence suggests that some …
Interstitial lung disease in systemic sclerosis: a simple staging system
…, CM Black, RM du Bois, AU Wells - American journal of …, 2008 - atsjournals.org
… Correspondence and requests for reprints should be addressed to Athol U. Wells, MD,
Interstitial Lung Disease Unit, Royal Brompton Hospital and NHLI, Imperial College, Emmanuel …
Interstitial Lung Disease Unit, Royal Brompton Hospital and NHLI, Imperial College, Emmanuel …
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically
significant, respiratory deterioration of unidentifiable cause. The objective of this …
significant, respiratory deterioration of unidentifiable cause. The objective of this …